Results 141 to 150 of about 4,025 (222)

Pyrazofurin Biosynthesis Involves Nonenzymatic Ring Contraction of a Pyridazine Intermediate Triggered by a Rieske Enzyme-Catalyzed Oxygenation. [PDF]

J Am Chem Soc
Zheng Z, Lee YH, Ren D, Liu HW.
europepmc   +1 more source

First example of an electropolymerizable heptazine bearing oligothiophene arms: a new way to produce well-defined heptazine-containing polymers. [PDF]

RSC Adv
Kulszewicz-Bajer I, Audebert P, Chand H, Banasiewicz M.   +3 more
europepmc   +1 more source

The quantitative haemodynamic effect of levosimendan, dobutamine, and milrinone in heart failure patients: a meta-analysis. [PDF]

ESC Heart Fail
Nuzzi V, Madaudo C, Manca P, Cannata A, Raffa G, Mulè M, Cannata S, La Franca E, Pisano C, Cipriani M, Lorusso R.   +10 more
europepmc   +1 more source

Bone Regeneration Drug BMP-7 Mitigates Ponatinib-Induced Cardiotoxicity via Inhibition of Pyroptosis and Modulation of TGF-β/SMAD Signaling Pathway. [PDF]

Cells
Rolando JM, Singla DK.
europepmc   +1 more source

Exploring the untapped pharmacological potential of imidazopyridazines. [PDF]

RSC Adv
Malik MS, Alshareef HF, Alfaidi KA, Ather H, Abduljaleel Z, Hussein EM, Moussa Z, Ahmed SA.   +7 more
europepmc   +1 more source

Subanesthetic doses of ketamine to rats and monkeys rapidly increases radioligand binding in brain to phosphodiesterase-4, an indirect marker of cAMP. [PDF]

Transl Psychiatry
Parcon PA, Bardhoshi A, Olsen-Dufour A, Cureton R, Jana S, Morse CL, Henter ID, Totis J, Jenson AE, Pamie-George MT, Liow JS, Zoghbi SS, Wu S, Pike VW, Innis RB.   +14 more
europepmc   +1 more source

Rh(iii)-catalyzed oxidative C-H annulation of 6-arylpyridazin-3(2<i>H</i>)-ones: direct access to diarylpyridazino[6,1-<i>a</i>]isoquinolin-5-ium-3-olates. [PDF]

RSC Adv
Ittamalla C, Mukundram NSS, Nagireddy J, Sridhar B, Reddy BVS.   +4 more
europepmc   +1 more source

Economic evaluation of ponatinib vs reference and generic imatinib in front-line management of philadelphia chromosome-positive acute lymphoblastic leukemia: A value dilemma. [PDF]

J Manag Care Spec Pharm
Amamoo RS, Schuerman B, Obeng-Kusi M, Yun S, Erstad B, Abraham I.   +5 more
europepmc   +1 more source

Efficient Approaches to the Design of Six-Membered Polyazocyclic Compounds-Part 2: Nonaromatic Frameworks. [PDF]

Molecules
Titova YY, Gyrgenova EA, Ivanov AV.
europepmc   +1 more source

Discovery of VU6025733 (AG06827): A Highly Selective, Orally Bioavailable, and Structurally Distinct M₄ Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM) with Robust <i>In Vivo</i> Efficacy. [PDF]

ACS Chem Neurosci
Gregro AR, Park C, Long MF, Baker LA, Bollinger KA, Ringuette AE, Peng L, Luscombe VB, Billard NB, Rodriguez AL, Niswender CM, Peng W, Dickerson JW, Rook JM, O'Neill J, Chang S, Boonen HCM, Jensen T, Thomsen MS, Bridges TM, Boutaud O, Conn PJ, Engers DW, Lindsley CW, Temple KJ.   +24 more
europepmc   +1 more source